In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs
- PMID: 12499228
- PMCID: PMC148996
- DOI: 10.1128/AAC.47.1.416-417.2003
In vitro activities of linezolid against clinical isolates of Mycobacterium tuberculosis that are susceptible or resistant to first-line antituberculous drugs
Abstract
We evaluated 117 isolates of Mycobacterium tuberculosis for susceptibility to linezolid by the proportion and E-test methods. Linezolid showed high in vitro activity, with all the strains inhibited by <or=1 microg of the drug per ml. E-test MICs were at least 4 dilutions lower than their equivalents by the standard proportion method.
References
-
- Agrawal, S., N. S. Thomas, A. B. Dhanikula, C. L. Kaul, and R. Panchagnula. 2001. Antituberculosis drugs and new drug development. Curr. Opin. Pulm. Med. 7:142-147. - PubMed
-
- Cercenado, E., F. Garcia-Garrote, and E. Bouza. 2001. In vitro activity of linezolid against multiply resistant Gram-positive clinical isolates. J. Antimicrob. Chemother. 47:77-81. - PubMed
-
- Dye, C., S. Scheele, P. Dolin, V. Pathania, and M. C. Raviglione. 1999. Global burden of tuberculosis. Estimated incidence, prevalence, and mortality by country. JAMA 282:677-686. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases